Arrowhead Pharmaceuticals (ARWR): are the analysts right?

Arrowhead Pharmaceuticals · Health Care · ref. ETF XLV · 85 calls · price $79.01
What the company does: Arrowhead Pharmaceuticals développe des médicaments pour traiter les maladies intraitables aux États-Unis.
📈 1-year price
$86.97+395.8% over range
Jul 8, 25low $14.71 · high $86.97Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
70% recommend buying · 10 analysts

🎯 Analyst price target on ARWR

High target · 1 analyst$110+39.2%
Median target · 10 analysts$87.5+10.7%
Low target · 1 analyst$46-41.8%
Current price$79.01

🗳️ The analyst consensus

Analyst breakdown · 10 (6 months)
Strong Buy0%
Buy70%
Hold30%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on ARWR

Most reliable analysts on ARWR (% profitable · 365j · ≥2 calls)
RBC Capital 100% +153.8% 2
Piper Sandler 100% +102.3% 2
HC Wainwright & Co. 83% +139.6% 12
Cantor Fitzgerald 63% +73.5% 8
B. Riley Securities 50% +42.0% 10
Chardan Capital 39% +39.7% 18

📊 What $1,000 invested in Arrowhead Pharmaceuticals would be worth

In short — $1,000 invested in Arrowhead Pharmaceuticals 10 years ago would be worth $13,254 today, i.e. +29%/yr on average. Best year: 2019 (+411%), worst: 2016 (-75%). Price performance, excluding dividends.

If I'd invested $1,000 in Arrowhead Pharmaceuticals

InvestmentWorth todayGain
1 years ago$4,336+334%
3 years ago$2,010+101%
5 years ago$1,062+6%
10 years ago$13,254+1225%
since inception (1994)$45.60-95%

Return by year (Arrowhead Pharmaceuticals)

YearReturn$1,000 invested at year start
2026 (YTD)+23%$1,228 (+23%)
2025+253%$4,336 (+334%)
2024-39%$2,664 (+166%)
2023-25%$2,010 (+101%)
2022-39%$1,229 (+23%)
2021-14%$1,062 (+6%)
2020+21%$1,285 (+29%)
2019+411%$6,563 (+556%)
2018+238%$22,149 (+2115%)
2017+137%$52,587 (+5159%)
2016-75%$13,254 (+1225%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on ARWR

■ Market Perform neutral · not a buy · 🎯$72
Price at call : $81.82 — gap to target -12%
Today : $79.01 — gap to target -9%
🎯 on ARWR : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Jun 17, 27
Bernstein
May 13, 26
■ Market Perform neutral · not a buy · 🎯$46
Price at call : $79.69 — gap to target -42%
Today : $79.01 — gap to target -42%
🎯 on ARWR : no call matured yet · 📊 on Health : 60% · +5.1% (5 calls)
in progress (365j)
matures : May 13, 27
RBC Capital
May 8, 26
▲ Outperform · 🎯$87
Price at call : $77.74 — upside +12%
Today : $79.01 — upside +10%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : May 8, 27
JP Morgan
May 1, 26
▲ Overweight · 🎯$88
Price at call : $74.81 — upside +18%
Today : $79.01 — upside +11%
🎯 on ARWR : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 1, 27
▲ Overweight · 🎯$100
Price at call : $71.05 — upside +41%
Today : $79.01 — upside +27%
🎯 on ARWR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Apr 21, 27
▲ Buy · 🎯$100
Price at call : $60.77 — upside +65%
Today : $79.01 — upside +27%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Mar 25, 27
▲ Buy · 🎯$100
Price at call : $62.92 — upside +59%
Today : $79.01 — upside +27%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 10, 27
▲ Buy · 🎯$101
Price at call : $69.59 — upside +45%
Today : $79.01 — upside +28%
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 50% · +21.5% (22 calls)
in progress (365j)
matures : Jan 22, 27
▲ Buy · 🎯$100
Price at call : $69.59 — upside +44%
Today : $79.01 — upside +27%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Jan 21, 27
Piper Sandler
Jan 13, 26
▲ Overweight · 🎯$110
Price at call : $65.91 — upside +67%
Today : $79.01 — upside +39%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Jan 13, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $65 — gap to target +31%
Today : $79.01 — gap to target +8%
🎯 on ARWR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Jan 7, 27
■ Equal-Weight neutral · not a buy · 🎯$81
Price at call : $65 — gap to target +25%
Today : $79.01 — gap to target +3%
🎯 on ARWR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jan 7, 27
▲ Buy · 🎯$80
Price at call : $65.69 — upside +22%
Today : $79.01 — upside +1%
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
in progress (365j)
matures : Jan 7, 27
Piper Sandler
Dec 17, 25
▲ Overweight · 🎯$100
Price at call : $64.8 — upside +54%
Today : $79.01 — upside +27%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Dec 17, 26
RBC Capital
Dec 11, 25
▲ Outperform · 🎯$80
Price at call : $70.09 — upside +14%
Today : $79.01 — upside +1%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Dec 11, 26
▲ Buy · 🎯$81
Price at call : $68.87 — upside +18%
Today : $79.01 — upside +3%
🎯 on ARWR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Dec 9, 26
▲ Buy · 🎯$85
Price at call : $57.95 — upside +47%
Today : $79.01 — upside +8%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Dec 2, 26
▲ Buy · 🎯$62
Price at call : $57.95 — upside +7%
Today : $79.01 — upside -22%
🎯 on ARWR : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Dec 1, 26
▲ Buy · 🎯$60
Price at call : $56.25 — upside +7%
Today : $79.01 — upside -24%
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
in progress (365j)
matures : Dec 1, 26
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $52.7 — gap to target -9%
Today : $79.01 — gap to target -39%
🎯 on ARWR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Nov 26, 26
Goldman Sachs
Nov 20, 25
■ Neutral neutral · not a buy · 🎯$48
Price at call : $38.09 — gap to target +26%
Today : $79.01 — gap to target -39%
🎯 on ARWR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Nov 20, 26
RBC Capital
Nov 19, 25
▲ Outperform · 🎯$52
Price at call : $38.09 — upside +37%
Today : $79.01 — upside -34%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Nov 19, 26
Chardan Capital
Nov 19, 25
▲ Buy · 🎯$60
Price at call : $38.97 — upside +54%
Today : $79.01 — upside -24%
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
in progress (365j)
matures : Nov 19, 26
Piper Sandler
Nov 19, 25
▲ Overweight · 🎯$70
Price at call : $38.97 — upside +80%
Today : $79.01 — upside -11%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Nov 19, 26
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $41.14 — gap to target +9%
Today : $79.01 — gap to target -43%
🎯 on ARWR : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Nov 12, 26
▲ Buy · 🎯$80
Price at call : $36.94 — upside +117%
Today : $79.01 — upside +1%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Oct 8, 26
▲ Buy · 🎯$80
Price at call : $27.8 — upside +188%
Today : $79.01 — upside +1%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 2, 26
Chardan Capital
Aug 11, 25
▲ Buy · 🎯$60
Price at call : $17.21 — upside +249%
Today : $79.01 — upside -24%
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
in progress (365j)
matures : Aug 11, 26
RBC Capital
Aug 8, 25
▲ Outperform · 🎯$38
Price at call : $17.21 — upside +121%
Today : $79.01 — upside -52%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Aug 8, 26
▲ Buy · 🎯$80
Price at call : $16.29 — upside +391%
Today : $79.01 — upside +1%
Expected +391% · Actual +374% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+373.5%
stock +374% · XLV +9%
Citigroup
May 13, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $14.91 — gap to target +14%
Today : $79.01 — gap to target -78%
🎯 on ARWR : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 13, 26
Chardan Capital
May 13, 25
▲ Buy · 🎯$60
Price at call : $15.28 — upside +293%
Today : $79.01 — upside -24%
Expected +293% · Actual +410% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
+409.7%
stock +410% · XLV +11%
▲ Buy · 🎯$38
Price at call : $20.44 — upside +86%
Today : $79.01 — upside -52%
Expected +86% · Actual +212% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 50% · +21.5% (22 calls)
+211.6%
stock +212% · XLV +9%
▲ Buy · 🎯$80
Price at call : $18.57 — upside +331%
Today : $79.01 — upside +1%
Expected +331% · Actual +236% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+235.9%
stock +236% · XLV +7%
RBC Capital
Feb 11, 25
▲ Outperform · 🎯$42
Price at call : $18.57 — upside +126%
Today : $79.01 — upside -47%
Expected +126% · Actual +236% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+235.9%
stock +236% · XLV +7%
Chardan Capital
Feb 11, 25
▲ Buy · 🎯$60
Price at call : $18.89 — upside +218%
Today : $79.01 — upside -24%
Expected +218% · Actual +226% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
+225.8%
stock +226% · XLV +7%
▲ Buy · 🎯$80
Price at call : $21.53 — upside +272%
Today : $79.01 — upside +1%
Expected +272% · Actual +211% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+211.4%
stock +211% · XLV +9%
▲ Buy · 🎯$80
Price at call : $19.71 — upside +306%
Today : $79.01 — upside +1%
Expected +306% · Actual +253% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+253.1%
stock +253% · XLV +11%
▲ Buy · 🎯$80
Price at call : $19.75 — upside +305%
Today : $79.01 — upside +1%
Expected +305% · Actual +249% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+249.4%
stock +249% · XLV +12%
Chardan Capital
Dec 12, 24
▲ Buy · 🎯$60
Price at call : $22.14 — upside +171%
Today : $79.01 — upside -24%
Expected +171% · Actual +217% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
+216.6%
stock +217% · XLV +9%
▲ Buy · 🎯$80
Price at call : $23.11 — upside +246%
Today : $79.01 — upside +1%
Expected +246% · Actual +180% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+179.8%
stock +180% · XLV +5%
Bernstein
Nov 29, 24
■ Market Perform neutral · not a buy · 🎯$24
Price at call : $26.03 — gap to target -8%
Today : $79.01 — gap to target -70%
🎯 on ARWR : no call matured yet · 📊 on Health : 60% · +5.1% (5 calls)
in progress (365j)
matures : Nov 29, 25
Piper Sandler
Nov 27, 24
▲ Overweight · 🎯$45
Price at call : $26.03 — upside +73%
Today : $79.01 — upside -43%
Expected +73% · Actual +102% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
+102.5%
stock +102% · XLV +7%
Citigroup
Nov 27, 24
■ Neutral neutral · not a buy · 🎯$26
Price at call : $26.03 — gap to target -0%
Today : $79.01 — gap to target -67%
🎯 on ARWR : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Nov 27, 25
Chardan Capital
Nov 27, 24
▲ Buy · 🎯$60
Price at call : $26.15 — upside +129%
Today : $79.01 — upside -24%
Expected +129% · Actual +102% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
+101.5%
stock +102% · XLV +7%
▲ Buy · 🎯$60
Price at call : $18.28 — upside +228%
Today : $79.01 — upside -24%
Expected +228% · Actual +121% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+121.3%
stock +121% · XLV +7%
▲ Buy · 🎯$60
Price at call : $19.36 — upside +210%
Today : $79.01 — upside -24%
Expected +210% · Actual +87% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+87.2%
stock +87% · XLV -8%
▲ Overweight · 🎯$62
Price at call : $17.84 — upside +248%
Today : $79.01 — upside -22%
Expected +248% · Actual +102% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
+102.1%
stock +102% · XLV -6%
RBC Capital
Sep 26, 24
▲ Outperform · 🎯$42
Price at call : $19.67 — upside +114%
Today : $79.01 — upside -47%
Expected +114% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+71.7%
stock +72% · XLV -11%
▲ Overweight
Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+34.6%
stock +35% · XLV -12%
▲ Buy · 🎯$60
Price at call : $23.25 — upside +158%
Today : $79.01 — upside -24%
Expected +158% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+25.1%
stock +25% · XLV -11%
▲ Buy · 🎯$60
Price at call : $23.98 — upside +150%
Today : $79.01 — upside -24%
Expected +150% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+16.8%
stock +17% · XLV -12%
▲ Buy · 🎯$55
Price at call : $22.85 — upside +141%
Today : $79.01 — upside -30%
Expected +141% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 50% · +21.5% (22 calls)
-12.5%
stock -13% · XLV -12%
▲ Buy · 🎯$60
Price at call : $28.91 — upside +108%
Today : $79.01 — upside -24%
Expected +108% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-43.8%
stock -44% · XLV -9%
Chardan Capital
Jul 17, 24
▲ Buy · 🎯$60
Price at call : $27.64 — upside +117%
Today : $79.01 — upside -24%
Expected +117% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
-39.4%
stock -39% · XLV -10%
▲ Buy · 🎯$60
Price at call : $25.57 — upside +135%
Today : $79.01 — upside -24%
Expected +135% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-34.1%
stock -34% · XLV -7%
Chardan Capital
Jun 26, 24
▲ Buy · 🎯$60
Price at call : $26.26 — upside +128%
Today : $79.01 — upside -24%
Expected +128% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
-38.8%
stock -39% · XLV -8%
▲ Overweight
Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
-39.2%
stock -39% · XLV -10%
▲ Buy · 🎯$60
Price at call : $25.29 — upside +137%
Today : $79.01 — upside -24%
Expected +137% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
-33.8%
stock -34% · XLV -8%
Chardan Capital
May 10, 24
▲ Buy · 🎯$60
Price at call : $22.06 — upside +172%
Today : $79.01 — upside -24%
Expected +172% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 39% (18 calls matureds) · 📊 on Health : 40.9% · +30.5% (22 calls)
-36.7%
stock -37% · XLV -5%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)